Registry of Patients Having Received oNKord®
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
CC-486 and Venetoclax for Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure
- Status
- TERMINATED
- Phase
- PHASE2
NK Cell Therapy for AML
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Venetoclax in Patients With MDS or AML in Relapse After AHSCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Assess an Interphase Cycle With Flotetuzumab.
- Status
- WITHDRAWN
- Phase
- PHASE2
Vinblastine for Leukoreduction in Newly Diagnosed AML and Hyperleukocytosis
- Status
- RECRUITING
- Phase
- PHASE2
Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML
- Status
- COMPLETED
- Phase
- PHASE2
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
- Status
- WITHDRAWN
- Phase
- N/A
Cardioprotection in AML
- Status
- RECRUITING
- Phase
- PHASE2
Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML
- Status
- WITHDRAWN
- Phase
- PHASE1
ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transplantation
- Status
- UNKNOWN
- Phase
- NA
Donor-derived CAR-T Cells in the Treatment of AML Patients
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2